Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00621751 · ClinicalTrials.gov registry record · NA
Carbamazepine for the Treatment of Chronic Post-Traumatic Brain Injury Irritability and Aggression
A NA study of Traumatic Brain Injury, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT00621751 is a NA study of Traumatic Brain Injury that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 70 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00621751, a NA study of Traumatic Brain Injury, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if carbamazepine reduces irritability and aggression among individuals with traumatic brain injury
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Carbamazepine
Study Locations (1)
North Carolina
- Carolinas Rehabilitation - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2008-02 |
| Est. Completion | 2013-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00621751
The ClinicalTrials.gov registry entry for NCT00621751 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (75% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00621751 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT00621751 about?
NCT00621751 is a clinical study titled "Carbamazepine for the Treatment of Chronic Post-Traumatic Brain Injury Irritability and Aggression". The purpose of this study is to determine if carbamazepine reduces irritability and aggression among individuals with traumatic brain injury
What is the current status of trial NCT00621751?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2008-02. Estimated completion is 2013-10.
What conditions does trial NCT00621751 study?
This clinical trial studies the following conditions: Traumatic Brain Injury.
What interventions are being tested in trial NCT00621751?
The interventions under investigation include: Placebo (DRUG), Carbamazepine (DRUG).
Who is sponsoring clinical trial NCT00621751?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00621751 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
tPBM in Older Adults With Traumatic Brain Injury
RECRUITING · NA
-
Carbon Dioxide Administration and Brain Waste Clearance
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Community-based Implementation of Online EmReg
RECRUITING · NA
-
Evaluation of the Abbott i-STAT TBI Biomarker Test
RECRUITING · NA
-
Long-term Brain Stimulation of the Motor Ventral Thalamus (VOP/VIM) to Improve Motor Function
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.